About
Frank Mattner is an Austrian biotech founder and scientific executive focused on Alzheimer’s disease and related neurodegenerative research. He co-founded AFFiRiS in 2003 and was publicly identified as its CSO, later also serving on its supervisory board. In 2021, he co-founded ADvantage Therapeutics, which is developing Alzheimer’s and longevity-related therapeutics.
Areas of interest
Alzheimer's diseaseneurodegenerationbiotechvaccinesimmunologylongevitymRNA therapeutics